Patrick Aouad

Postdoc @Genentech 🇺🇸 - PhD/Postdoc @EPFL🇨🇭- M.S @AUB_Lebanon 🇱🇧 Hormone Receptor+ #BreastCancer, #Metastasis, and #Endocrine_Therapy.

[Patrick Aouad @PatrikAouad]

Myoepithelial cells of the human breast are fascinating. Here’s my recent 3D temporal-color code of the myoepithelial cells in a cleared human breast specimen. Right on time for the #Voir_Est_Savoir exhibition. Thanks @CBrisken for the opportunity. #Mammary_Gland #BriskenLab

[Patrick Aouad @PatrikAouad]

@DrSusanNasif Thanks, Susan ☺️🙏🏽. Yes I am curious. DM me 🎉

[Patrick Aouad @PatrikAouad]

The final open-access version of our review article is now available here: https://t.co/bOTfLfzxBK
Please check it out! #Breast_Cancer #BreastCancer #Metastasis #Models

[Patrick Aouad @PatrikAouad]

I am really excited to share that our review on preclinical models of breast cancer metastasis is out in npj Breast Cancer! We provide a comprehensive overview of the major preclinical models used to study breast cancer metastasis @sflomos @NadineDarwiche https://t.co/bOTfLfzxBK

[Paolo Tarantino @PTarantinoMD]

Whenever I see presentation slides fully designed by AI, a switch turns off in my brain. My attention suddenly drops.

The content may be ok. But realizing that they are AI-generated, and not knowing how much human input/review is included, makes me less engaged.

Is it just me?

[Patrick Aouad @PatrikAouad]

Ligand-activated AR promotes the survival of endocrine therapy-responsive ER+ breast cancer https://t.co/b8RlaJrCx8

[Stephen V Liu, MD @StephenVLiu]

Top-line results from randomized phase III Krascendo 1 trial shows divarasib superior to first generation KRAS G12C inhibitors with improved PFS and significant improvement in OS, meeting primary endpoint. Eagerly awaiting data presentation!

https://t.co/u5RpqQZbto

[Mark Lewis, MD, FASCO @marklewismd]

Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer

Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived

#ASCO26

[Patrick Aouad @PatrikAouad]

I am really excited to share that our review on preclinical models of breast cancer metastasis is out in npj Breast Cancer! We provide a comprehensive overview of the major preclinical models used to study breast cancer metastasis @sflomos @NadineDarwiche https://t.co/bOTfLfzxBK

[Patrick Aouad @PatrikAouad]

@elias_mikael Scary

[Patrick Aouad @PatrikAouad]

Thank you @MammaryCell for always highlighting my work in mammary gland and breast cancer research since my PhD days :). Review on preclinical models of breast cancer metastasis is now OUT; please check it out: https://t.co/bOTfLfzxBK @sflomos

[Mammary Cell News @MammaryCell]

Congrats to Drs. @PatrikAouad, Nadine Darwiche, Karim Halabi, and the entire team on their new @Nature_NPJ #review! 🙌

They summarize the strengths and limitations of different animal models in recapitulating key stages of #BreastCancer #metastasis.

📚: https://t.co/hlVihhiXQD

[Mammary Cell News @MammaryCell]

Congrats to Drs. @PatrikAouad, Nadine Darwiche, Karim Halabi, and the entire team on their new @Nature_NPJ #review! 🙌

They summarize the strengths and limitations of different animal models in recapitulating key stages of #BreastCancer #metastasis.

📚: https://t.co/hlVihhiXQD

[George Sflomos @sflomos]

This review will be a super useful tool to people working with preclinical models!

[OncoDaily @oncodaily]

Major Preclinical Models Used to Study Breast Cancer Metastasis - Patrick Aouad

@PatrikAouad @sflomos

https://t.co/ZkfjOzogEg

#OncoDaily #Oncology #Cancer #Health #Medicine #BreastCancerResearch #MedX #MedTwitter

[Patrick Aouad @PatrikAouad]

@MammaryCell @Nature_NPJ Thank you very much for sharing our recently published review! 🙏🏼🙂
Please note that this is not my picture.

[Patrick Aouad @PatrikAouad]

@sflomos @NadineDarwiche Thank you very much. Your expertise was appreciated in this review!

[Patrick Aouad @PatrikAouad]

I am really excited to share that our review on preclinical models of breast cancer metastasis is out in npj Breast Cancer! We provide a comprehensive overview of the major preclinical models used to study breast cancer metastasis @sflomos @NadineDarwiche https://t.co/bOTfLfzxBK

[Pilar Baldominos @PBaldominos]

GRC Chairs: Gillian Farnie & @EGlezSuarezlab
GRS Chairs: Pilar Baldominos & Jorge Gomez-Miragaya Image credits: @PatrikAouad winner of the first Mammary Gland Biology GRS contest to feature the conference image

[Patrick Aouad @PatrikAouad]

Happy Postdoc Appreciation Week to all my fellow postdocs! 🎉

[Patrick Aouad @PatrikAouad]

EMT and cancer: what clinicians should know https://t.co/DL6eSIpAuv

[Muhammad Hussain, MD @whosainastro]

1/
Why is Ki-67 called Ki-67? And why am I attaching a photo of this beautiful city to the tweet?
If you work in pathology or oncology, you’ve likely come across Ki-67 many times. But where does the name come from?

A short 🧵 on the origins, function, and significance of Ki-67. #IHC #pathx #molpath

[Patrick Aouad @PatrikAouad]

@sflomos Thanks for the live updates G!!!